You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2011 or most recent year available
Part (v) Inpatient clients by secondary drug and primary drug
| Secondary drug | Amphetamines | MDMA and other derivatives |
|---|---|---|
| Opioids | 370 | 6 |
| Cocaine | 119 | 14 |
| Stimulants (other than cocaine) | 152 | 16 |
| Hypnotics and sedatives | 325 | 4 |
| Hallucinogens | 60 | 7 |
| Volatile | 25 | 0 |
| Cannabis | 1433 | 29 |
| Alcohol | 507 | 12 |
| Other substances | 56 | 2 |
| Total number of citations | 3047 | 90 |
Notes
Clients may report one primary drug, but more than one secondary drug
For information relative to the countries included please see Table TDI-7
The number of treatment clients in each country is listed in Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — Table TDI by centre type.